Former FDA Official Joins 3D Communications' Scientific and Regulatory Advisory Board

WASHINGTON, Feb. 14, 2013 /PRNewswire/ -- 3D Communications today announced the expansion of its FDA Scientific and Regulatory Advisory Board with the appointment of Andrea Leonard-Segal, MD. Dr. Leonard-Segal is the recent Director of the Division of Nonprescription Clinical Evaluation (DNCE) in the FDA Center for Drug Evaluation and Research (CDER).

3D's Scientific and Regulatory Advisory Board provides 3D Communications with guidance and ad hoc support to help clients prepare for FDA interactions and FDA advisory committee meetings. The Board is comprised of former FDA officials, FDA advisory committee members, and doctors and scientists with extensive approval experience.

Dr. Leonard-Segal, co-founder of Andrea Leonard-Segal M.D. and Melissa Furness Consulting LLC, will offer companies scientific and regulatory assessment and strategy on drug development programs in all phases of clinical development.

"I am excited about this new chapter in my career to help companies with their drug development and submission programs," says Dr. Leonard-Segal. "I'm also looking forward to the opportunity to work on 3D's Board with such renowned FDA regulatory and advisory committee experts."

"We are honored to have Dr. Leonard-Segal on our Advisory Board," said 3D Communications co-founder Cindy DiBiasi. "She brings FDA expertise and crucial insights on current regulatory thinking and the inner workings at the FDA to our clients who are seeking product approval."

The 3D Science and Regulatory Advisory Board includes:
http://www.3dcommunications.us/who.html#Advisory

Eric Brass, MD, PhD, Board Chair
Gregory Burkhart, MD
Bruce Burlington, MD
Louis R. Cantilena, Jr., MD, PhD
William Hiatt, MD
Heidi M. Jolson, MD, MPH
Andrea Leonard-Segal, MD
Martin B. Leon, MD
Paul Waymack, MD, ScD
Janet Wittes, PhD

For more information about 3D Communications, visit www.3dcommunications.us, or call 202-236-4625.

3D Communications is a strategic communications firm that prepares companies for high-stakes regulatory presentations, meetings, and media interviews. Our expertise lies in transforming highly complex information into clear and persuasive communications. 3D's team of seasoned experts use a proven process, based on proprietary tools, to help companies succeed. Our services include strategic analysis, messaging, content development, speaker and media training, crisis management, and preparation for early and late-stage regulatory communications. For more information, visit www.3dcommunications.us.

SOURCE 3D Communications